[1]黄启林,杨屹,罗晨 李帅,等.胎盘间充质干细胞移植对大鼠重症急性胰腺炎的保护作用[J].第三军医大学学报,2020,42(07):646-655.
 HUANG Qilin,YANG Yi LUO Chen,LI Shuai,et al.Protective effect of placenta-derived mesenchymal stem cell transplantation against severe acute pancreatitis in rats[J].J Third Mil Med Univ,2020,42(07):646-655.
点击复制

胎盘间充质干细胞移植对大鼠重症急性胰腺炎的保护作用(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第07期
页码:
646-655
栏目:
基础医学
出版日期:
2020-04-15

文章信息/Info

Title:
Protective effect of placenta-derived mesenchymal stem cell transplantation against severe acute pancreatitis in rats
作者:
黄启林杨屹罗晨 李帅汤礼军孙红玉
西南交通大学医学院;西部战区总医院胰腺损伤与修复四川省重点实验室
Author(s):
HUANG Qilin1 YANG Yi LUO Chen LI Shuai TANG Lijun SUN Hongyu

College of Medicine, Southwest Jiaotong University, Chengdu, 610031, Sichuan Province; Key Laboratory of Pancreatic Injury and Repair of Sichuan Province,  General Hospital of Western Theater Command, Chengdu, 610083, Sichuan Province, China

关键词:
间充质干细胞移植重症急性胰腺炎胎盘巨噬细胞
Keywords:
mesenchymal stem cells transplantation severe acute pancreatitis placenta macrophages
分类号:
R329.1; R576; R61
文献标志码:
A
摘要:

目的 研究胎盘间充质干细胞(placenta-derived mesenchymal stem cells, P-MSCs)对大鼠重症急性胰腺炎(severe acute pancreatitis, SAP)的保护作用。方法健康成年雄性SD大鼠32只,随机分为对照组、P-MSCs组、SAP组和SAP+P-MSCs组,每组8只。采用4%牛磺胆酸钠胆胰管逆行注射法建立SAP大鼠模型,造模结束后12 h与36 h经尾静脉注射P-MSCs(1×106个/100 g)。大鼠在P-MSCs第一次输注后72 h处死,HE染色评估胰腺损伤程度,ELISA法测定血清中炎症因子、淀粉酶与脂肪酶浓度,qRT-PCR检测胰腺组织中炎症因子基因表达水平,免疫组化法检测胰腺组织中巨噬细胞浸润情况。结果体外输注的P-MSCs有向损伤部位定植的特性。与SAP组相比,SAP+P-MSCs组胰腺病理评分明显降低(P<0.05);血清中淀粉酶、脂肪酶、IL-1β、IL-6与TNF-α浓度明显降低(P<0.05),而IL-10、IL-4和TGF-β浓度明显升高(P<0.05);胰腺组织中IL-1β与TNF-α mRNA表达水平明显降低(P<0.05),IL-10与IL-4 mRNA表达水平明显升高(P<0.05)。此外,P-MSCs可以有效减轻胰腺组织中巨噬细胞浸润。结论P-MSCs能有效减轻SAP大鼠胰腺局部炎症反应与全身炎症反应,其减轻胰腺局部炎症反应可能与其减少胰腺局部巨噬细胞与中性粒细胞浸润有关。

Abstract:

ObjectiveTo investigate the protective effects of human placenta-derived mesenchymal stem cell (P-MSC) transplantation against severe acute pancreatitis (SAP) in rats. MethodsA total of 32 healthy adult male Sprague-Dawley (SD) rats were randomly divided into control group, P-MSC group, SAP and SAP+P-MSCs group (n=8), and in the latter 2 groups, SAP was induced by retrograde injection of 4% sodium taurocholate into the common biliopancreatic duct. P-MSCs (1×106 cells/100 g) were delivered through the tail vein of the rats at 12 and 36 h after the induction of SAP. All the rats were sacrificed 72 h after the first P-MSC infusion. HE staining was used to assess the pancreatic pathologies of the rats after the treatments. The serum levels of the pro- and anti-inflammatory mediators, amylase and lipase were determined by ELISA, and the mRNA expression levels of the inflammatory mediators in the pancreatic tissue were detected using qRT-PCR. Immunohistochemistry was performed to examine macrophage infiltration in the pancreatic tissue of the rats. ResultsHoming of the infused P-MSCs to the injury site was observed in the rats with SAP. Transplantation of P-MSCs significantly ameliorated histopathological injury and lowered pancreatic pathological score of the pancreas, reduced serum levels of amylase, lipase, interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) (P<0.05), increased serum levels of IL-10, IL-4 and transforming growth factor-β (TGF-β) (P<0.05), decreased the expression levels of IL-1β and TNF-α (P<0.05) and increased the expression of IL-10 and IL-4 in the pancreatic tissue (P<0.05) of the rats with SAP. In addition, P-MSC transplantation effectively reduced macrophage infiltration in the pancreatic tissue of the rats. ConclusionTransplantation of P-MSCs can effectively alleviate local inflammatory response in the pancreas and systemic inflammatory response in rats with SAP probably by reducing local macrophage and neutrophil infiltration in the pancreas.

参考文献/References:

[1]FORSMARK C E, SWAROOP VEGE S, WILCOX C M. Acute pancreatitis[J]. N Engl J Med, 2016, 375(20): 1972-1981. DOI: 10.1056/nejmra1505202.
[2]GUKOVSKAYA A S, GUKOVSKY I, ALGL H, et al. Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis[J]. Gastroenterology, 2017, 153(5): 1212-1226. DOI: 10.1053/j.gastro.2017.08.071.
[3]MANOHAR M, VERMA A K, VENKATESHAIAH S U, et al. Pathogenic mechanisms of pancreatitis[J]. World J Gastrointest Pharmacol Ther, 2017, 8(1): 10. DOI: 10.4292/wjgpt.v8.i1.10.
[4]SHRIVASTAVA P, BHATIA M. Essential role of monocytes and macrophages in the progression of acute pancreatitis[J]. World J Gastroenterol, 2010, 16(32): 3995-4002. DOI: 10.3748/wjg.v16.i32.3995.
[5]GEA-SORL S, CLOSA D. Role of macrophages in the progression of acute pancreatitis[J]. World J Gastrointest Pharmacol Ther, 2010, 1(5): 107-111. DOI: 10.4292/wjgpt.v1.i5.107.
[6]JUNG K H, SONG S N, YI T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats[J]. Gastroenterology, 2011, 140(3): 998-1008. DOI: 10.1053/j.gastro.2010.11.047.
[7]WALTER J, WARE L B, MATTHAY M A. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis[J]. Lancet Respir Med, 2014, 2(12): 1016-1026. DOI: 10.1016/S2213-2600(14)70217-6.
[8]MA Z L, SONG G D, ZHAO D B, et al. Bone marrow-derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase-1-mediated anti-oxidant and anti-inflammatory effects[J]. Cytotherapy, 2019, 21(2): 162-174. DOI: 10.1016/j.jcyt.2018.11.013.
[9]QIAN D H, SONG G D, MA Z L, et al. MicroRNA-9 modified bone marrow-derived mesenchymal stem cells (BMSCs) repair severe acute pancreatitis (SAP) via inducing angiogenesis in rats[J]. Stem Cell Res Ther, 2018, 9(1): 282. DOI: 10.1186/s13287-018-1022-y.
[10]YANG J, SU J, XI S S, et al. Human umbilical cord mesenchymal stem cells pretreated with angiotensin-Ⅱ attenuate pancreas injury of rats with severe acute pancreatitis[J]. Biomedecine Pharmacother, 2019, 117: 109052. DOI: 10.1016/j.biopha.2019.109052.
[11]HUANG Q,YANG Y, LUO C, et al. An efficient protocol to generate placental chorionic plate-derived mesenchymal stem cells with superior proliferative and immunomodulatory properties[J]. Stem Cell Res Ther, 2019, 10(1): 301. DOI: 10.1186/s13287-019-1405-8.
[12]SCHMIDT J, RATTNER D W, LEWANDROWSKI K, et al. A better model of acute pancreatitis for evaluating therapy[J]. Ann Surg, 1992, 215(1): 44-56. DOI: 10.1097/00000658-199201000-00007.
[13]SHI Y F, WANG Y, LI Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases[J]. Nat Rev Nephrol, 2018, 14(8): 493-507. DOI: 10.1038/s41581-018-0023-5.
[14]SHI Y H, SHI H, NOMI A, et al. Mesenchymal stem cell-derived extracellular vesicles: a new impetus of promoting angiogenesis in tissue regeneration[J]. Cytotherapy, 2019, 21(5): 497-508. DOI: 10.1016/j.jcyt.2018.11.012.
[15]LIANG L, LI Z J, MA T, et al. Transplantation of human placenta-derived mesenchymal stem cells alleviates critical limb ischemia in diabetic nude rats[J]. Cell Transplant, 2017, 26(1): 45-61. DOI: 10.3727/096368916X69 2726.
[16]KAWAKUBO K, OHNISHI S, KUWATANI M, et al. Mesenchymal stem cell therapy for acute and chronic pancreatitis[J]. J Gastroenterol, 2018, 53(1): 1-5. DOI: 10.1007/s00535-017-1363-9.
[17]AHMED S M, MORSI M, GHONEIM N I, et al. Mesenchymal stromal cell therapy for pancreatitis: A systematic review[J]. Oxid Med Cell Longev, 2018, 2018: 3250864. DOI: 10.1155/2018/3250864.
[18]XU LL, LIU Y M, SUN Y X, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue[J]. Stem Cell Res Ther, 2017, 8(1): 275. DOI: 10.1186/s13287-017-0716-x.
[19]LI X Y, BAI J P, JI X F, et al. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation[J]. Int J Mol Med, 2014, 34(3): 695-704. DOI: 10.3892/ijmm.2014.1821.
[20]TALWADEKAR M D, KALE V P, LIMAYE L S. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study[J]. Sci Rep, 2015, 5: 15784. DOI: 10.1038/srep15784.
[21]DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement[J]. Cytotherapy, 2006, 8(4): 315-317. DOI: 10.1080/14653240600855905.
[22]ZHAO W A, PHINNEY D G, BONNET D, et al. Mesenchymal stem cell biodistribution, migration, and homing in vivo[J]. Stem Cells Int, 2014, 2014: 292109. DOI: 10.1155/2014/292109.
[23]HE Z G, HUA J, QIAN D H, et al. Intravenous hMSCs ameliorate acute pancreatitis in mice via secretion of tumor necrosis factor-α stimulated gene/protein 6[J]. Sci Rep, 2016, 6: 38438. DOI: 10.1038/srep38438.
[24]QU B, CHU Y J, ZHU F, et al. Granulocyte colony-stimulating factor enhances the therapeutic efficacy of bone marrow mesenchymal stem cell transplantation in rats with experimental acute pancreatitis[J]. Oncotarget, 2017, 8(13): 21305-21314. DOI: 10.18632/oncotarget.15515.

相似文献/References:

[1]赵洪雯,余荣杰,刘宏,等.内皮祖细胞移植对延缓大鼠进展性局灶节段性肾小球硬化的实验研究[J].第三军医大学学报,2007,29(21):2044.
 ZHAO Hong-wen,YU Rong-jie,LIU Hong,et al.Endothelial progenitor cells transplantation ameliorates the progression of progressive focal segmental glomerular sclerosis[J].J Third Mil Med Univ,2007,29(07):2044.
[2]王雨,王爱民,孙红振,等.髋关节置换术中髋臼骨缺损的处理及其疗效分析[J].第三军医大学学报,2007,29(17):1716.
 WANG Yu,WANG Ai-min,SUN Hong-zhen,et al.Treatment of acetabular defects in total hip replacement[J].J Third Mil Med Univ,2007,29(07):1716.
[3]王贵波,王晓芹,罗高兴,等.多功能医学实验平台的研制及在体外细胞温度效应观察中的初步应用[J].第三军医大学学报,2007,29(13):1289.
 WANG Gui-bo,WANG Xiao-qin,LUO Gao-xing,et al.Design of a multifunction medical experiment platform and its temperature regulation in cell in vitro culture[J].J Third Mil Med Univ,2007,29(07):1289.
[4]胡晶,冯敏,杨慧,等.当归多糖动员的造血干/祖细胞移植重建小鼠造血功能的研究[J].第三军医大学学报,2007,29(23):2236.
 HU Jing,FENG Min,YANG Hui,et al.Hematopoiesis reconstruction in mice of hematopoietic aplasia by transplanting hematopoietic stem/progenitor cells mobilized by Angelica polysaccharides[J].J Third Mil Med Univ,2007,29(07):2236.
[5]卫静,袁发焕,周剑峰,等.BMP-7基因修饰的骨髓间充质干细胞在小鼠肾脏内的表达[J].第三军医大学学报,2008,30(10):906.
 WEI Jing,YUAN Fa-huan,ZHOU Jian-feng,et al.Expression of BMP-7 gene modified bone marrow mesenchymal stem cells in the kidneys of mice[J].J Third Mil Med Univ,2008,30(07):906.
[6]陆德宾,陈兵,梁自文,等.自体骨髓间充质干细胞移植治疗糖尿病足1例[J].第三军医大学学报,2007,29(11):1125.
[7]武强,李露斯,范文辉,等.小鼠胚胎神经干细胞海马移植对APP/PS1双转基因AD小鼠的治疗作用[J].第三军医大学学报,2007,29(10):915.
 WU Qiang,LI Lu-si,FAN Wen-hui,et al.Therapeutic effect of mouse embryonic neural stem cells replacement into hippocampus of APP/PS1 double transgenic mice of Alzheimer disease[J].J Third Mil Med Univ,2007,29(07):915.
[8]谢峰,杨柳,郭林,等.关节镜下应用同种异体髌腱联合重建前后交叉韧带的临床随访研究[J].第三军医大学学报,2007,29(07):626.
 XIE Feng,YANG Liu,GUO Lin,et al.A follow-up study of arthroscopically assisted combined reconstruction of anterior and posterior cruciate ligaments with allogeneic patellar tendon[J].J Third Mil Med Univ,2007,29(07):626.
[9]王红勇,何作云,于长青,等.自体骨骼肌卫星细胞移植对心肌梗死大鼠心功能的影响[J].第三军医大学学报,2006,28(24):2444.
[10]王树森,房崇云,曾梦华,等.可溶性HLA-G1抑制人自然杀伤细胞NK92对猪内皮细胞PED的黏附[J].第三军医大学学报,2006,28(17):1746.

更新日期/Last Update: 2020-04-07